HELIX BIOPHARMA CORP (HBP.CA) Stock Income Statement
Canada - TSX:HBP - CA4229102088 - Common Stock
2.4 CAD
-0.01 (-0.41%)
| TTM (2025-4-30) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Operating Expenses | 9.70M | 9.24M | 6.33M | 6.04M | 9.13M | |||
| Research and Development | 5.95M | 6.09M | 5.27M | 4.53M | 5.71M | |||
| Selling, General, and Administrative Expenses | 3.77M | 3.26M | 1.04M | 1.50M | 3.25M | |||
| Operating Income | -9.70M | -9.24M | -6.33M | -6.04M | -9.13M | |||
| Interest Income/Expense | -117.00K | -25.00K | 31.00K | -23.00K | 37.00K | |||
| Other Income/Expense | N/A | N/A | 0.00 | -500.00K | -480.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -9.53M | -9.26M | -6.29M | -6.56M | -9.57M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -9.53M | -9.26M | -6.29M | -6.56M | -8.04M | |||
| EBITDA | -9.69M | -9.22M | -6.31M | -6.03M | -8.93M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.19 | -0.21 | -0.16 | -0.22 | -0.29 | |||
| Statistics | ||||||||
All data in CAD